Michael D. Altman

3.4k total citations
49 papers, 1.7k citations indexed

About

Michael D. Altman is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Michael D. Altman has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Infectious Diseases and 9 papers in Oncology. Recurrent topics in Michael D. Altman's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (7 papers) and Computational Drug Discovery Methods (7 papers). Michael D. Altman is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (7 papers) and Computational Drug Discovery Methods (7 papers). Michael D. Altman collaborates with scholars based in United States, Switzerland and Türkiye. Michael D. Altman's co-authors include Shuguang Zhang, Bruce Tidor, Jacob White, Jaydeep P. Bardhan, Celia A. Schiffer, George M. Whitesides, Helen M. Nugent, Lin Yan, Felice Frankel and Alexander Rich and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and The Journal of Chemical Physics.

In The Last Decade

Michael D. Altman

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Altman United States 23 826 320 316 296 252 49 1.7k
Pehr B. Harbury United States 29 3.9k 4.7× 145 0.5× 374 1.2× 273 0.9× 186 0.7× 46 4.9k
Nectarios Klonis Australia 33 930 1.1× 194 0.6× 263 0.8× 47 0.2× 121 0.5× 50 3.2k
Manfred Roessle Germany 25 1.9k 2.3× 133 0.4× 113 0.4× 132 0.4× 152 0.6× 55 3.0k
Neil Voss United States 16 1.9k 2.2× 236 0.7× 96 0.3× 67 0.2× 107 0.4× 24 2.7k
John L. Kulp United States 18 528 0.6× 163 0.5× 120 0.4× 296 1.0× 100 0.4× 41 1.1k
Adam Round France 34 2.5k 3.0× 122 0.4× 146 0.5× 166 0.6× 169 0.7× 80 3.9k
Alain Chaffotte France 27 2.1k 2.6× 151 0.5× 121 0.4× 77 0.3× 138 0.5× 67 3.1k
Volker Knecht Germany 24 1.0k 1.2× 99 0.3× 111 0.4× 83 0.3× 182 0.7× 47 1.4k
Jelle Hendrix Belgium 27 1.2k 1.5× 491 1.5× 110 0.3× 70 0.2× 119 0.5× 62 2.3k
Nilesh K. Banavali United States 23 2.3k 2.8× 180 0.6× 165 0.5× 35 0.1× 209 0.8× 53 2.9k

Countries citing papers authored by Michael D. Altman

Since Specialization
Citations

This map shows the geographic impact of Michael D. Altman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Altman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Altman more than expected).

Fields of papers citing papers by Michael D. Altman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Altman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Altman. The network helps show where Michael D. Altman may publish in the future.

Co-authorship network of co-authors of Michael D. Altman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Altman. A scholar is included among the top collaborators of Michael D. Altman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Altman. Michael D. Altman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawamura, Shuhei, Hai‐Young Kim, Josep Saurí, et al.. (2022). Design and synthesis of unprecedented 9- and 10-membered cyclonucleosides with PRMT5 inhibitory activity. Bioorganic & Medicinal Chemistry. 66. 116820–116820. 6 indexed citations
2.
Fradera, Xavier, Qiaolin Deng, Solomon D. Kattar, et al.. (2021). Discovery of a new series of PI3K-δ inhibitors from Virtual Screening. Bioorganic & Medicinal Chemistry Letters. 42. 128046–128046. 2 indexed citations
3.
Fradera, Xavier, Joey L. Methot, Matthew Christopher, et al.. (2019). Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow. Bioorganic & Medicinal Chemistry Letters. 29(18). 2575–2580. 15 indexed citations
4.
Günaydin, Hakan, Michael D. Altman, J. Michael Ellis, et al.. (2018). Strategy for Extending Half-life in Drug Design and Its Significance. ACS Medicinal Chemistry Letters. 9(6). 528–533. 44 indexed citations
5.
Baker, James Α., Michael D. Altman, & Iain Martin. (2018). Interpretation of in Vitro Metabolic Stability Studies for Racemic Mixtures. ACS Medicinal Chemistry Letters. 9(8). 843–847. 2 indexed citations
6.
Haidle, Andrew M., Jason D. Katz, James P. Jewell, et al.. (2016). MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation. Bioorganic & Medicinal Chemistry Letters. 27(1). 109–113. 3 indexed citations
7.
Katz, Jason D., Andrew M. Haidle, James P. Jewell, et al.. (2016). Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(1). 114–120. 13 indexed citations
8.
Sloman, David L., Michael D. Altman, Dapeng Chen, et al.. (2016). Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties. Bioorganic & Medicinal Chemistry Letters. 26(17). 4362–4366. 9 indexed citations
9.
Lim, Jongwon, Michael D. Altman, James Α. Baker, et al.. (2015). Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4. ACS Medicinal Chemistry Letters. 6(6). 683–688. 31 indexed citations
10.
Lim, Jongwon, Michael D. Altman, James Α. Baker, et al.. (2015). Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications. Bioorganic & Medicinal Chemistry Letters. 25(22). 5384–5388. 22 indexed citations
11.
Haidle, Andrew M., Craig Rosenstein, Michael D. Altman, et al.. (2014). Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms. Bioorganic & Medicinal Chemistry Letters. 24(8). 1968–1973. 9 indexed citations
12.
Siu, Tony, Michael D. Altman, Matthew H. Katcher, et al.. (2014). The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 24(6). 1466–1471. 6 indexed citations
13.
Nalam, M.N.L., Akbar Ali, G. Sudhakar Reddy, et al.. (2013). Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance. Chemistry & Biology. 20(9). 1116–1124. 50 indexed citations
14.
Shen, Yang, Michael D. Altman, Akbar Ali, et al.. (2013). Testing the Substrate-Envelope Hypothesis with Designed Pairs of Compounds. ACS Chemical Biology. 8(11). 2433–2441. 27 indexed citations
15.
Siu, Tony, Joon Jung, Craig Rosenstein, et al.. (2010). The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead. Bioorganic & Medicinal Chemistry Letters. 20(24). 7421–7425. 22 indexed citations
16.
Huggins, David J., Michael D. Altman, & Bruce Tidor. (2008). Evaluation of an inverse molecular design algorithm in a model binding site. Proteins Structure Function and Bioinformatics. 75(1). 168–186. 8 indexed citations
17.
Reddy, G. Sudhakar, Akbar Ali, M.N.L. Nalam, et al.. (2007). Design of Mutation‐resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis. Chemical Biology & Drug Design. 69(5). 298–313. 43 indexed citations
18.
Altman, Michael D., E.A. Nalivaika, M. Prabu-Jeyabalan, Celia A. Schiffer, & Bruce Tidor. (2007). Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV‐1 protease. Proteins Structure Function and Bioinformatics. 70(3). 678–694. 38 indexed citations
19.
Bardhan, Jaydeep P., Michael D. Altman, Shaun M. Lippow, Bruce Tidor, & Jacob White. (2005). A Curved Panel Integration Technique for Molecular Surfaces. TechConnect Briefs. 1(2005). 512–515. 1 indexed citations
20.
Altman, Michael D., Jaydeep P. Bardhan, Jacob White, & Bruce Tidor. (2005). An Accurate Surface Formulation for Biomolecule Electrostatics in Non-Ionic Solutions. PubMed. 2005. 7591–7595. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pehr B. Harbury Breakdown of academic impact, for papers by Nectarios Klonis Breakdown of academic impact, for papers by Manfred Roessle Breakdown of academic impact, for papers by Neil Voss Breakdown of academic impact, for papers by John L. Kulp Breakdown of academic impact, for papers by Adam Round Breakdown of academic impact, for papers by Alain Chaffotte Breakdown of academic impact, for papers by Volker Knecht Breakdown of academic impact, for papers by Jelle Hendrix Breakdown of academic impact, for papers by Nilesh K. Banavali
Rankless by CCL
2026